A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of E-WE Thrombin as an Intravenous Bolus in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2018
At a glance
- Drugs E-WE Thrombin (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Aronora
- 15 Jun 2018 Planned End Date changed from 1 Sep 2018 to 1 Nov 2018.
- 15 Jun 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Nov 2018.
- 16 May 2018 Status changed from not yet recruiting to recruiting.